{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:16:06Z","timestamp":1793153766899,"version":"4.5.0"},"reference-count":199,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Frontotemporal Dementia (FTD), and Amyotrophic lateral sclerosis (ALS) are complex and fatal neurodegenerative diseases. While current treatments for these diseases do alleviate some symptoms, there is an imperative need for novel treatments able to stop their progression. For all of these ailments, most cases occur sporadically and have no known genetic cause. Only a small percentage of patients bear known mutations which occur in a multitude of genes. Hence, it is clear that genetic factors alone do not explain disease occurrence. Chromatin, a DNA-histone complex whose basic unit is the nucleosome, is divided into euchromatin, an open form accessible to the transcriptional machinery, and heterochromatin, which is closed and transcriptionally inactive. Protruding out of the nucleosome, histone tails undergo post-translational modifications (PTMs) including methylation, acetylation, and phosphorylation which occur at specific residues and are connected to different chromatin structural states and regulate access to transcriptional machinery. Epigenetic mechanisms, including histone PTMs and changes in chromatin structure, could help explain neurodegenerative disease processes and illuminate novel treatment targets. Recent research has revealed that changes in histone PTMs and heterochromatin loss or gain are connected to neurodegeneration. Here, we review evidence for epigenetic changes occurring in AD, PD, and FTD\/ALS. We focus specifically on alterations in the histone PTMs landscape, changes in the expression of histone modifying enzymes and chromatin remodelers as well as the consequences of these changes in heterochromatin structure. We also highlight the potential for epigenetic therapies in neurodegenerative disease treatment. Given their reversibility and pharmacological accessibility, epigenetic mechanisms provide a promising avenue for novel treatments. Altogether, these findings underscore the need for thorough characterization of epigenetic mechanisms and chromatin structure in neurodegeneration.<\/jats:p>","DOI":"10.3389\/fnmol.2024.1456052","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T01:11:52Z","timestamp":1726189912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics"],"prefix":"10.3389","volume":"17","author":[{"given":"Raven M. A.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P.","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnins.2020.00042","article-title":"The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia","volume":"14","author":"Abramzon","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0141836","DOI":"10.1371\/journal.pone.0141836","article-title":"Transcriptomic changes due to cytoplasmic TDP-43 expression reveal dysregulation of histone transcripts and nuclear chromatin","volume":"10","author":"Amlie-Wolf","year":"2015","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"15307","DOI":"10.1073\/pnas.1201632109","article-title":"Role of genes linked to sporadic Alzheimer\u2019s disease risk in the production of \u03b2-amyloid peptides","volume":"109","author":"Bali","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson\u2019s disease and the environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbadis.2010.01.011","article-title":"Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS","volume":"1802","author":"Barbosa","year":"2010","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1038\/s41467-020-19722-9","article-title":"Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes","volume":"11","author":"Barbour","year":"2020","journal-title":"Nat. Commun."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"18265","DOI":"10.1038\/s41598-020-75035-3","article-title":"Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases","volume":"10","author":"Beaver","year":"2020","journal-title":"Sci. Rep."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","article-title":"Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood","volume":"126","author":"Belzil","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.clinthera.2023.06.016","article-title":"Sodium phenylbutyrate\/taurursodiol","volume":"45","author":"Beninger","year":"2023","journal-title":"Clin. Ther."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1021\/acs.biochem.1c00455","article-title":"Trichostatin a relieves growth suppression and restores histone acetylation at specific sites in a FUS ALS\/FTD yeast model","volume":"60","author":"Bennett","year":"2021","journal-title":"Biochemistry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trsl.2018.10.002","article-title":"Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease","volume":"204","author":"Bennett","year":"2019","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","article-title":"SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity","volume":"12","author":"Berdy\u0144ski","year":"2022","journal-title":"Sci. Rep."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1016\/j.cub.2017.10.024","article-title":"TDP-43 promotes neurodegeneration by impairing chromatin remodeling","volume":"27","author":"Berson","year":"2017","journal-title":"Curr. Biol. CB"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.3390\/ijerph18136976","article-title":"The olfactory system as marker of neurodegeneration in aging, neurological and neuropsychiatric disorders","volume":"18","author":"Bhatia-Dey","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"108921","DOI":"10.1016\/j.isci.2024.108921","article-title":"Parkinson\u2019s disease risk enhancers in microglia","volume":"27","author":"Booms","year":"2024","journal-title":"iScience"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2016.05.013","article-title":"The aging epigenome","volume":"62","author":"Booth","year":"2016","journal-title":"Mol. Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1128\/MCB.00205-14","article-title":"Polycomb repressive complex 2 and H3K27me3 cooperate with H3K9 methylation to maintain heterochromatin protein 1\u03b1 at chromatin","volume":"34","author":"Boros","year":"2014","journal-title":"Mol. Cell. Biol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Mol. Basel Switz."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12864-015-2058-3","article-title":"Blood transcriptomics of drug-na\u00efve sporadic Parkinson\u2019s disease patients","volume":"16","author":"Calligaris","year":"2015","journal-title":"BMC Genomics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfr239","article-title":"The role of environmental exposures in neurodegeneration and neurodegenerative diseases","volume":"124","author":"Cannon","year":"2011","journal-title":"Toxicol. Sci."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"eabc8096","DOI":"10.1126\/sciadv.abc8096","article-title":"Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer\u2019s disease","volume":"6","author":"Cao","year":"2020","journal-title":"Sci. Adv."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fnagi.2018.00137","article-title":"Histone deacetylase inhibitor alleviates the neurodegenerative phenotypes and histone dysregulation in presenilins-deficient mice","volume":"10","author":"Cao","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2200023","DOI":"10.1111\/boc.202200023","article-title":"Chromatin epigenetics and nuclear lamina keep the nucleus in shape: examples from natural and accelerated aging","volume":"115","author":"Carollo","year":"2023","journal-title":"Biol. Cell."},{"key":"ref27","first-page":"51","article-title":"Chromatin modulation by histone deacetylase inhibitors: impact on cellular sensitivity to ionizing radiation","volume":"5","author":"Carrier","year":"2013","journal-title":"Mol. Cell. Pharmacol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"706145","DOI":"10.3389\/fneur.2021.706145","article-title":"Frequency of heterozygous Parkin (PRKN) variants and penetrance of Parkinson\u2019s disease risk markers in the population-based CHRIS cohort","volume":"12","author":"Castelo Rueda","year":"2021","journal-title":"Front. Neurol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-023-00499-9","article-title":"Molecular phenotypes of mitochondrial dysfunction in clinically non-manifesting heterozygous PRKN variant carriers","volume":"9","author":"Castelo Rueda","year":"2023","journal-title":"Npj Park. Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/1389202914666131210195808","article-title":"Genetic insights into sporadic Parkinson\u2019s disease pathogenesis","volume":"14","author":"Chai","year":"2013","journal-title":"Curr. Genomics"},{"key":"ref31","first-page":"407","article-title":"Neurodegenerative diseases","volume":"163","author":"Checkoway","year":"2011","journal-title":"IARC Sci. Publ."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acschemneuro.7b00297","article-title":"Neurodegenerative disease proteinopathies are connected to distinct histone post-translational modification landscapes","volume":"9","author":"Chen","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2300334","DOI":"10.1002\/adbi.202300334","article-title":"Cytoplasmic accumulation of histones induced by BET inhibition protects cells from C9orf72 poly(PR)-induced cell death","volume":"8","author":"Chen","year":"2024","journal-title":"Adv. Biol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13059-018-1398-0","article-title":"Precise genome-wide mapping of single nucleosomes and linkers in vivo","volume":"19","author":"Chereji","year":"2018","journal-title":"Genome Biol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","article-title":"Cellular senescence is induced by the environmental neurotoxin Paraquat and contributes to neuropathology linked to Parkinson\u2019s disease","volume":"22","author":"Chinta","year":"2018","journal-title":"Cell Rep."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/ph14010029","article-title":"Role of Edaravone as a treatment option for patients with amyotrophic lateral sclerosis","volume":"14","author":"Cho","year":"2020","journal-title":"Pharmaceuticals"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12929-022-00890-3","article-title":"Modulation of histone H3K4 dimethylation by spermidine ameliorates motor neuron survival and neuropathology in a mouse model of ALS","volume":"29","author":"Choi","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41537-022-00326-9","article-title":"Metabolic contributions to neuronal deficits caused by genomic disruption of schizophrenia risk gene SETD1A","volume":"8","author":"Chong","year":"2022","journal-title":"Schizophrenia"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1212\/WNL.0000000000013123","article-title":"Amyotrophic lateral sclerosis\u2013frontotemporal dementia: shared and divergent neural correlates across the clinical spectrum","volume":"98","author":"Cividini","year":"2022","journal-title":"Neurology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.bbadis.2018.10.019","article-title":"The impact of histone post-translational modifications in neurodegenerative diseases","volume":"1865","author":"Cobos","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-021-01150-5","article-title":"Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS\/FTD","volume":"9","author":"Coyne","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2297450","DOI":"10.1080\/19420862.2023.2297450","article-title":"Antibodies to watch in 2024","volume":"16","author":"Crescioli","year":"2024","journal-title":"MAbs"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17482960802320487","article-title":"Phase 2 study of sodium phenylbutyrate in ALS","volume":"10","author":"Cudkowicz","year":"2009","journal-title":"Amyotroph. Lateral Scler"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e47866","DOI":"10.7554\/eLife.47866","article-title":"Elevating acetyl-CoA levels reduces aspects of brain aging","volume":"8","author":"Currais","year":"2019","journal-title":"eLife"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41525-021-00243-3","article-title":"Contribution of rare variant associations to neurodegenerative disease presentation","volume":"6","author":"Dilliott","year":"2021","journal-title":"Npj Genomic Med."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e0194661","DOI":"10.1371\/journal.pone.0194661","article-title":"Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion","volume":"13","author":"Dresselhaus","year":"2018","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jagp.2023.08.017","article-title":"Identifying and diagnosing TDP-43 neurodegenerative diseases in psychiatry","volume":"32","author":"Ducharme","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","article-title":"Histone deacetylase inhibitors as anticancer drugs","volume":"18","author":"Eckschlager","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1038\/s41467-021-26147-5","article-title":"Polycomb condensates can promote epigenetic marks but are not required for sustained chromatin compaction","volume":"12","author":"Eeftens","year":"2021","journal-title":"Nat. Commun."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41598-018-37444-3","article-title":"Heterochromatic genome instability and neurodegeneration sharing similarities with Alzheimer\u2019s disease in old Bmi1+\/\u2212 mice","volume":"9","author":"El Hajjar","year":"2019","journal-title":"Sci. Rep."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.conb.2019.07.001","article-title":"An emerging perspective on \u2018histone code\u2019 mediated regulation of neural plasticity and disease","volume":"59","author":"Farrelly","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13148-022-01419-z","article-title":"Drugging the epigenome in the age of precision medicine","volume":"15","author":"Feehley","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-023-00619-2","article-title":"Opinion: more mouse models and more translation needed for ALS","volume":"18","author":"Fisher","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.celrep.2018.04.097","article-title":"Modeling late-onset sporadic Alzheimer\u2019s disease through BMI1 deficiency","volume":"23","author":"Flamier","year":"2018","journal-title":"Cell Rep."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"S509","DOI":"10.1002\/mds.22021","article-title":"Levodopa-related motor complications--phenomenology","volume":"23","author":"Fox","year":"2008","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2017.00035","article-title":"The role of dipeptide repeats in C9ORF72-related ALS-FTD","volume":"10","author":"Freibaum","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cub.2015.11.039","article-title":"Lamin dysfunction mediates neurodegeneration in Tauopathies","volume":"26","author":"Frost","year":"2016","journal-title":"Curr. Biol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nn.3639","article-title":"Tau promotes neurodegeneration through global chromatin relaxation","volume":"17","author":"Frost","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/nar\/gkg332","article-title":"The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase","volume":"31","author":"Fuks","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10072-012-1151-5","article-title":"Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration","volume":"34","author":"Galimberti","year":"2013","journal-title":"Neurol. Sci."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.3233\/JAD-2012-129036","article-title":"TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43","volume":"33","author":"Gendron","year":"2013","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e37234","DOI":"10.7554\/eLife.37234","article-title":"Bundling up DNA","volume":"7","author":"Gerbi","year":"2018","journal-title":"eLife"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2011-110824","article-title":"The role of variation at A\u03b2PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer\u2019s disease","volume":"28","author":"Gerrish","year":"2012","journal-title":"J. Alzheimers Dis. JAD"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/ijms21051841","article-title":"Perinuclear Lamin a and Nucleoplasmic Lamin B2 characterize two types of hippocampal neurons through Alzheimer\u2019s disease progression","volume":"21","author":"Gil","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbamcr.2018.07.016","article-title":"Protein phosphatases in chromatin structure and function","volume":"1866","author":"Gil","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1073\/pnas.96.6.2852","article-title":"The tail domain of Lamin Dm 0 binds histones H2A and H2B","volume":"96","author":"Goldberg","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/CON.0000000000000309","article-title":"Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia","volume":"22","author":"Gomperts","year":"2016","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Gr\u00e4ff","year":"2012","journal-title":"Nature"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"13343","DOI":"10.1038\/ncomms13343","article-title":"BMI1 regulates PRC1 architecture and activity through homo- and hetero-oligomerization","volume":"7","author":"Gray","year":"2016","journal-title":"Nat. Commun."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0092-8674(02)01074-7","article-title":"Integration of long-term-memory-related synaptic plasticity involves bidirectional regulation of gene expression and chromatin structure","volume":"111","author":"Guan","year":"2002","journal-title":"Cell"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e12188","DOI":"10.15252\/emmm.202012188","article-title":"Targeted attenuation of elevated histone marks at SNCA alleviates \u03b1-synuclein in Parkinson\u2019s disease","volume":"13","author":"Guhathakurta","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.3390\/molecules27134160","article-title":"A class I HDAC inhibitor rescues synaptic damage and neuron loss in APP-transfected cells and APP\/PS1 mice through the GRIP1\/AMPA pathway","volume":"27","author":"Han","year":"2022","journal-title":"Molecules"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/nrm1829","article-title":"A binary switch","volume":"6","author":"Heinrichs","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"e74305","DOI":"10.1371\/journal.pone.0074305","article-title":"Epigenetic induction of EGR-1 expression by the amyloid precursor protein during exposure to novelty","volume":"8","author":"Hendrickx","year":"2013","journal-title":"PLoS One"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"e99467","DOI":"10.1371\/journal.pone.0099467","article-title":"Epigenetic regulations of immediate early genes expression involved in memory formation by the amyloid precursor protein of Alzheimer disease","volume":"9","author":"Hendrickx","year":"2014","journal-title":"PLoS One"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"a019364","DOI":"10.1101\/cshperspect.a019364","article-title":"Histone variants and epigenetics","volume":"7","author":"Henikoff","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2443.2008.01266.x","article-title":"Nucleo-cytoplasmic shuttling of protein arginine methyltransferase 1 (PRMT1) requires enzymatic activity","volume":"14","author":"Herrmann","year":"2009","journal-title":"Genes Cells"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1101\/gad.1333905","article-title":"Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications","volume":"19","author":"Huang","year":"2005","journal-title":"Genes Dev."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"492","DOI":"10.17912\/micropub.biology.000492","article-title":"Changes in histone H3 acetylation on lysine 9 accompany A\u03b2 1-40 overexpression in an Alzheimer\u2019s disease yeast model","volume":"2021","author":"Hugais","year":"2021","journal-title":"MicroPublication Biol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn.2017.46","article-title":"The emerging field of epigenetics in neurodegeneration and neuroprotection","volume":"18","author":"Hwang","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"e324","DOI":"10.1038\/emm.2017.11","article-title":"Writing, erasing and reading histone lysine methylations","volume":"49","author":"Hyun","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fnagi.2020.00004","article-title":"Strategies for the treatment of Parkinson\u2019s disease: beyond dopamine","volume":"12","author":"Iarkov","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/NEN.0b013e3181ddd404","article-title":"Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis","volume":"69","author":"Janssen","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"276","DOI":"10.21307\/ane\u20112019\u2011026","article-title":"The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson\u2019s disease","volume":"79","author":"J\u0119\u015bko","year":"2019","journal-title":"Acta Neurobiol. Exp."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1523\/JNEUROSCI.5634-10.2011","article-title":"\u03b1-Synuclein negatively regulates protein kinase C\u03b4 expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity","volume":"31","author":"Jin","year":"2011","journal-title":"J. Neurosci."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13148-020-0816-9","article-title":"Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice","volume":"12","author":"Jury","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1025473","DOI":"10.3389\/fnagi.2022.1025473","article-title":"The role of altered protein acetylation in neurodegenerative disease","volume":"14","author":"Kabir","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.1678","article-title":"Epigenetic modifications as therapeutic targets","volume":"28","author":"Kelly","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref96","author":"Khan","year":"2023"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/mnfr.201600194","article-title":"Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways","volume":"61","author":"Kim","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1749-6632.2009.04105.x","article-title":"Linking cell cycle reentry and DNA damage in neurodegeneration","volume":"1170","author":"Kim","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1212\/WNL.0000000000207438","article-title":"Implications of the approval of Lecanemab for Alzheimer disease patient care: incremental step or paradigm shift?","volume":"101","author":"Knopman","year":"2023","journal-title":"Neurology"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13148-020-00941-2","article-title":"Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy","volume":"12","author":"Komar","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"\u03b1-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00018-023-04769-w","article-title":"ALS is imprinted in the chromatin accessibility of blood cells","volume":"80","author":"K\u00fchlwein","year":"2023","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1113\/jphysiol.2010.190926","article-title":"Significance of SGK1 in the regulation of neuronal function","volume":"588","author":"Lang","year":"2010","journal-title":"J. Physiol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature22822","article-title":"Liquid droplet formation by HP1\u03b1 suggests a role for phase separation in heterochromatin","volume":"547","author":"Larson","year":"2017","journal-title":"Nature"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"a026575","DOI":"10.1101\/cshperspect.a026575","article-title":"Role of the polycomb repressive complex 2 (PRC2) in transcriptional regulation and Cancer","volume":"6","author":"Laugesen","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1038\/s12276-020-00497-4","article-title":"Heterochromatin: an epigenetic point of view in aging","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/1570159X15666170601124220","article-title":"Chromatin changes associated with neuronal maintenance and their pharmacological application","volume":"16","author":"Lee","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"e13153","DOI":"10.1111\/acel.13153","article-title":"Epigenome signatures landscaped by histone H3K9me3 are associated with the synaptic dysfunction in Alzheimer\u2019s disease","volume":"19","author":"Lee","year":"2020","journal-title":"Aging Cell"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2021.09.008","article-title":"Tau and MAPT genetics in tauopathies and synucleinopathies","volume":"90","author":"Leveille","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1038\/s41467-023-41033-y","article-title":"Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.neurobiolaging.2012.12.028","article-title":"Disruption of neocortical histone H3 homeostasis by soluble A\u03b2: implications for Alzheimer\u2019s disease","volume":"34","author":"Lithner","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.tins.2019.10.003","article-title":"Editing the epigenome to tackle brain disorders","volume":"42","author":"Liu","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.celrep.2019.04.003","article-title":"Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons","volume":"27","author":"Liu","year":"2019","journal-title":"Cell Rep."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/biology12121529","article-title":"The impact of apolipoprotein E (APOE) epigenetics on aging and sporadic Alzheimer\u2019s disease","volume":"12","author":"Lozupone","year":"2023","journal-title":"Biology"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00401-011-0838-7","article-title":"Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-018-0565-6","article-title":"The involvement of tau in nucleolar transcription and the stress response","volume":"6","author":"Maina","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/genes12020208","article-title":"Novel approaches to epigenetic therapies: from drug combinations to epigenetic editing","volume":"12","author":"Majchrzak-Celi\u0144ska","year":"2021","journal-title":"Genes"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.bpj.2020.05.014","article-title":"A Lamin-associated chromatin model for chromosome organization","volume":"118","author":"Maji","year":"2020","journal-title":"Biophys. J."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"33047","DOI":"10.1038\/srep33047","article-title":"Loss of tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin","volume":"6","author":"Mansuroglu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol. Cell"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbagrm.2008.07.009","article-title":"Histone modifying enzymes: structures, mechanisms, and specificities","volume":"1789","author":"Marmorstein","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1101\/cshperspect.a018762","article-title":"Writers and readers of histone acetylation: structure, mechanism, and inhibition","volume":"6","author":"Marmorstein","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"175590","DOI":"10.1016\/j.ejphar.2023.175590","article-title":"Use of histone methyltransferase inhibitors in cancer treatment: a systematic review","volume":"944","author":"Marzochi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2018.08.009","article-title":"Epigenetic changes associated with the expression of amyotrophic lateral sclerosis (ALS) causing genes","volume":"390","author":"Masala","year":"2018","journal-title":"Neuroscience"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/ijms20040878","article-title":"Hippocampal LMNA gene expression is increased in late-stage Alzheimer\u2019s disease","volume":"20","author":"M\u00e9ndez-L\u00f3pez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/genes11050556","article-title":"Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability","volume":"11","author":"Milazzo","year":"2020","journal-title":"Genes"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41576-022-00468-7","article-title":"Histone post-translational modifications \u2014 cause and consequence of genome function","volume":"23","author":"Mill\u00e1n-Zambrano","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"102067","DOI":"10.1016\/j.arr.2023.102067","article-title":"Neuroepigenetics of ageing and neurodegeneration-associated dementia: an updated review","volume":"91","author":"Mir","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"e20230072","DOI":"10.1590\/1980-5764-DN-2023-0072","article-title":"A comprehensive review on frontotemporal dementia: its impact on language, speech and behavior","volume":"18","author":"Mollah","year":"2024","journal-title":"Dement. Neuropsychol."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13148-016-0223-4","article-title":"Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy","volume":"8","author":"Morera","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.3390\/ijms22136922","article-title":"Molecular complexes at Euchromatin, heterochromatin and centromeric chromatin","volume":"22","author":"Morrison","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41419-020-03105-5","article-title":"Therapeutic effect of a histone demethylase inhibitor in Parkinson\u2019s disease","volume":"11","author":"Mu","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41556-020-00620-7","article-title":"CRISPR technologies for precise epigenome editing","volume":"23","author":"Nakamura","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00401-003-0684-3","article-title":"Ectopic localization of phosphorylated histone H3 in Alzheimer\u2019s disease: a mitotic catastrophe?","volume":"105","author":"Ogawa","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuron.2020.01.020","article-title":"Nucleocytoplasmic proteomic analysis uncovers eRF1 and nonsense-mediated decay as modifiers of ALS\/FTD C9orf72 toxicity","volume":"106","author":"Ortega","year":"2020","journal-title":"Neuron"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era","volume":"11","author":"Paez-Colasante","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3390\/diagnostics11030509","article-title":"Amyotrophic lateral sclerosis and frontotemporal lobar degenerations: similarities in genetic background","volume":"11","author":"Parobkova","year":"2021","journal-title":"Diagnostics"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/s0167-4781(99)00166-9","article-title":"Activation of Smad1-mediated transcription by p300\/CBP","volume":"1489","author":"Pearson","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"579137","DOI":"10.3389\/fcell.2020.579137","article-title":"Heterochromatin as an important driver of genome organization","volume":"8","author":"Penagos-Puig","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer\u2019s disease with iPSC-derived brain cells","volume":"25","author":"Penney","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"R546","DOI":"10.1016\/j.cub.2004.07.007","article-title":"Histones and histone modifications","volume":"14","author":"Peterson","year":"2004","journal-title":"Curr. Biol."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neuron.2024.01.013","article-title":"Epigenetic dysregulation in Alzheimer\u2019s disease peripheral immunity","volume":"112","author":"Ramakrishnan","year":"2024","journal-title":"Neuron"},{"key":"ref145","article-title":"Alzheimer\u2019s drug with modest benefits wins backing of FDA advisers","volume-title":"Nature","author":"Reardon","year":"2024"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.celrep.2015.08.076","article-title":"Engrailed homeoprotein protects mesencephalic dopaminergic neurons from oxidative stress","volume":"13","author":"Rekaik","year":"2015","journal-title":"Cell Rep."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40478-019-0750-2","article-title":"Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model","volume":"7","author":"Rossaert","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.bbagrm.2014.03.001","article-title":"Interpreting the language of histone and DNA modifications","volume":"1839","author":"Rothbart","year":"2014","journal-title":"Biochim. Biophys. Acta BBA Gene Regul. Mech."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"12720","DOI":"10.1038\/srep12720","article-title":"Histone H4 acetylation required for chromatin decompaction during DNA replication","volume":"5","author":"Ruan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref151","doi-asserted-by":"publisher","first-page":"e16140","DOI":"10.1111\/ene.16140","article-title":"Breaking barriers with tofersen: enhancing therapeutic opportunities in amyotrophic lateral sclerosis","volume":"31","author":"Saini","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref152","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JPD-130186","article-title":"Levodopa in the treatment of Parkinson\u2019s disease: current status and new developments","volume":"3","author":"Salat","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41419-020-2580-3","article-title":"HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo","volume":"11","author":"Sanna","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"e00070","DOI":"10.7554\/eLife.00070","article-title":"The activity-dependent histone variant H2BE modulates the life span of olfactory neurons","volume":"1","author":"Santoro","year":"2012","journal-title":"eLife"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.stemcr.2023.10.003","article-title":"Is epigenome editing non-inheritable? Implications for ethics and the regulation of human applications","volume":"18","author":"Sasaki-Honda","year":"2023","journal-title":"Stem Cell Rep."},{"key":"ref156","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-012-0996-2","article-title":"The genetics and neuropathology of Alzheimer\u2019s disease","volume":"124","author":"Schellenberg","year":"2012","journal-title":"Acta Neuropathol."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1038\/s41467-023-42862-7","article-title":"A reversible state of hypometabolism in a human cellular model of sporadic Parkinson\u2019s disease","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat. Commun."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1091\/mbc.E14-05-1007","article-title":"FUS is sequestered in nuclear aggregates in ALS patient fibroblasts","volume":"25","author":"Schwartz","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"ref159","article-title":"Genetics, histone code","volume-title":"StatPearls","author":"Shahid","year":"2023"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1242\/jcs.02907","article-title":"Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization","volume":"119","author":"Sj\u00f6berg","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1123621","DOI":"10.3389\/fcell.2023.1123621","article-title":"Epigenetic modification in Parkinson\u2019s disease","volume":"11","author":"Song","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/hmg\/ddu616","article-title":"Mendelian genes for Parkinson\u2019s disease contribute to the sporadic forms of the disease\u2020","volume":"24","author":"Spataro","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref163","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-031-15080-7_184","article-title":"Mechanisms underlying long-latency neurodegenerative diseases of environmental origin","volume-title":"Handbook of neurotoxicity","author":"Spencer","year":"2022"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.brainres.2018.02.011","article-title":"Synaptic dysfunction and altered excitability in C9ORF72 ALS\/FTD","volume":"1693","author":"Starr","year":"2018","journal-title":"Brain Res."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"a009399","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-synuclein in Parkinson\u2019s disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1091\/mbc.E17-06-0410","article-title":"Chromatin histone modifications and rigidity affect nuclear morphology independent of lamins","volume":"29","author":"Stephens","year":"2018","journal-title":"Mol. Biol. Cell"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"36328","DOI":"10.1038\/srep36328","article-title":"\u03b1-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses","volume":"6","author":"Sugeno","year":"2016","journal-title":"Sci. Rep."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.3390\/ijms19103199","article-title":"Pharmacoepigenomic interventions as novel potential treatments for Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"19","author":"Teijido","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cmet.2010.09.004","article-title":"Histone methyl-transferases and demethylases; can they link metabolism and transcription?","volume":"12","author":"Teperino","year":"2010","journal-title":"Cell Metab."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/hmg\/ddu494","article-title":"Cytoplasmic sequestration of FUS\/TLS associated with ALS alters histone marks through loss of nuclear protein arginine methyltransferase 1","volume":"24","author":"Tibshirani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1093\/hmg\/ddx301","article-title":"Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis","volume":"26","author":"Tibshirani","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-021-00450-7","article-title":"Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain","volume":"16","author":"Toker","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"e24747","DOI":"10.1371\/journal.pone.0024747","article-title":"Proteomic interrogation of human chromatin","volume":"6","author":"Torrente","year":"2011","journal-title":"PLoS One"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","article-title":"Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease","volume":"9","author":"Tsalenchuk","year":"2023","journal-title":"Npj Park. Dis."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.3390\/ijms24054778","article-title":"Toward the development of epigenome editing-based therapeutics: potentials and challenges","volume":"24","author":"Ueda","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.2174\/13816128113199990382","article-title":"Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders","volume":"19","author":"Valor","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref179","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2017.04.022","article-title":"Lamina-associated domains: links with chromosome architecture, heterochromatin, and gene repression","volume":"169","author":"van Steensel","year":"2017","journal-title":"Cell"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/j.1460-2075.1996.tb00608.x","article-title":"Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro","volume":"15","author":"Vettese-Dadey","year":"1996","journal-title":"EMBO J."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1261\/rna.071191.119","article-title":"C9orf72 and triplet repeat disorder RNAs: G-quadruplex formation, binding to PRC2 and implications for disease mechanisms","volume":"25","author":"Wang","year":"2019","journal-title":"RNA"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"9912686","DOI":"10.1155\/2021\/9912686","article-title":"Epigenetic modulation of microglia function and phenotypes in neurodegenerative diseases","volume":"2021","author":"Wang","year":"2021","journal-title":"Neural Plast."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"e12452","DOI":"10.1002\/trc2.12452","article-title":"Phase 1 study of latozinemab in progranulin-associated frontotemporal dementia","volume":"10","author":"Ward","year":"2024","journal-title":"Alzheimers Dement. Transl. Res. Clin. Interv."},{"key":"ref184","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/sj.emboj.7601954","article-title":"14-3-3 proteins recognize a histone code at histone H3 and are required for transcriptional activation","volume":"27","author":"Winter","year":"2008","journal-title":"EMBO J."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jamaneurol.2017.0469","article-title":"Genome-wide pleiotropy between Parkinson disease and autoimmune diseases","volume":"74","author":"Witoelar","year":"2017","journal-title":"JAMA Neurol."},{"key":"ref186","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fncel.2013.00279","article-title":"Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS","volume":"7","author":"Wong","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"e10622","DOI":"10.15252\/emmm.201910622","article-title":"HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies","volume":"12","author":"Wu","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"e3002559","DOI":"10.1371\/journal.pbio.3002559","article-title":"Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence","volume":"22","author":"Wu","year":"2024","journal-title":"PLoS Biol."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1093\/hmg\/ddt662","article-title":"TDP-43 causes differential pathology in neuronal versus glial cells in the mouse brain","volume":"23","author":"Yan","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","article-title":"The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease","volume":"6","author":"Yang","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin a initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.4161\/cc.8.11.8620","article-title":"Histone H3-K56 acetylation is important for genomic stability in mammals","volume":"8","author":"Yuan","year":"2009","journal-title":"Cell Cycle Georget. Tex"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/cr.2011.42","article-title":"Readers of histone modifications","volume":"21","author":"Yun","year":"2011","journal-title":"Cell Res."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"101794","DOI":"10.1016\/j.jbc.2022.101794","article-title":"Degradation and inhibition of epigenetic regulatory protein BRD4 exacerbate Alzheimer\u2019s disease-related neuropathology in cell models","volume":"298","author":"Zhang","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref195","doi-asserted-by":"publisher","first-page":"eaav2606","DOI":"10.1126\/science.aav2606","article-title":"Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity","volume":"363","author":"Zhang","year":"2019","journal-title":"Science"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"a025064","DOI":"10.1101\/cshperspect.a025064","article-title":"Comprehensive catalog of currently documented histone modifications","volume":"7","author":"Zhao","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref197","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/brain\/awy354","article-title":"Inhibition of EHMT1\/2 rescues synaptic and cognitive functions for Alzheimer\u2019s disease","volume":"142","author":"Zheng","year":"2019","journal-title":"Brain"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref199","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/epigenomes4030015","article-title":"Epigenomic remodeling in Huntington\u2019s disease-master or servant?","volume":"4","author":"Zimmer-Bensch","year":"2020","journal-title":"Epigenomes"}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2024.1456052\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T01:12:03Z","timestamp":1726189923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2024.1456052\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":199,"alternative-id":["10.3389\/fnmol.2024.1456052"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2024.1456052","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,13]]},"article-number":"1456052"}}